随着时间推移，CAR T细胞治疗患者COVID-19预后改善：欧洲血液和骨髓移植学会（EBMT）感染性疾病工作组（IDWP）及欧洲血液学会（EHA）淋巴瘤组的欧洲多中心研究更新
Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group
DOI 原文链接
用sci-hub下载
如无法下载，请从 Sci-Hub 选择可用站点尝试。
正在获取期刊数据...
发表日期:2024 Sep
作者:
DOI:10.1038/s41375-024-02336-1
摘要
AI正在翻译并加载中文摘要...